Clinical characteristics and outcomes between children and adults with anti-N-Methyl-d-Aspartate receptor encephalitis

Journal of Neurology

Volumn 263, Issue 12, 2016, Pages 2446-2455

  Huang, Qi ^a   Wu, Yuan ^a   Qin, Rongfa ^a   Wei, Xing ^a   Ma, Meigang ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Adults; Anti NMDAR encephalitis; Children; Prognosis; Status epilepticus

Indexed keywords

ANTICONVULSIVE AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; GLUCOSE; IMMUNOGLOBULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; NEUROLEPTIC AGENT; PROTEIN; ANTIBODY; IMMUNOLOGIC FACTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NR1 NMDA RECEPTOR;

ABNORMAL BEHAVIOR; ADOLESCENT; ADULT; ADULT DISEASE; ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ARTICLE; AUTONOMIC DYSFUNCTION; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CLINICAL OUTCOME; COGNITIVE DEFECT; CONSCIOUSNESS LEVEL; CONTROLLED STUDY; CONVALESCENCE; CORTICOSTEROID THERAPY; ELECTROENCEPHALOGRAM; EPILEPTIC STATE; FEMALE; FOLLOW UP; GROUPS BY AGE; HOSPITALIZATION; HUMAN; HYPOVENTILATION; IMMUNOTHERAPY; INTENSIVE CARE; MALE; MIDDLE AGED; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSERVATIONAL STUDY; PLASMA EXCHANGE; PNEUMONIA; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR; SCHOOL CHILD; SPEECH DISORDER; YOUNG ADULT; AGE; AGING; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; CEREBROSPINAL FLUID; DIAGNOSTIC IMAGING; DRUG EFFECTS; ELECTROENCEPHALOGRAPHY; GENETIC TRANSFECTION; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; METABOLISM; NONPARAMETRIC TEST; PHYSIOLOGY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGE FACTORS; AGING; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; ANTIBODIES; BRAIN WAVES; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HEK293 CELLS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RECEPTORS, N-METHYL-D-ASPARTATE; RETROSPECTIVE STUDIES; STATISTICS, NONPARAMETRIC; TRANSFECTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84988409830     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-016-8282-1     Document Type: Article

References (29)

1. Graus F, Titulaer MJ, Balu R et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404
2. Zekeridou A, Karantoni E, Viaccoz A et al (2015) Treatment and outcome of children and adolescents with N-methyl-d-aspartate receptor encephalitis. J Neurol 262:1859–1866
3. Dalmau J, Tuzun E, Wu HY et al (2007) Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61:25–36
4. Gable MS, Sheriff H, Dalmau J et al (2012) The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 54:899–904
5. Titulaer MJ, McCracken L, Gabilondo I et al (2013) Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 12:157–165
6. Irani SR, Bera K, Waters P et al (2010) N-methyl-d-aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133:1655–1667
7. Brzek A, Nowak Z, Plewa M (2002) Modified programme of in-patient (phase I) cardiac rehabilitation after acute myocardial infarction. Int J Rehabil Res 25:225–229
8. Johnston SC, Siedenberg R, Min JK et al (1997) Central apnea and acute cardiac ischemia in a sheep model of epileptic sudden death. Ann Neurol 42:588–594
9. Claassen J, Riviello JJ Jr, Silbergleit R (2015) Emergency neurological life support: status epilepticus. Neurocrit Care 23(Suppl 2):S136–S142
10. Veciana M, Becerra JL, Fossas P et al (2015) EEG extreme delta brush: an ictal pattern in patients with anti-NMDA receptor encephalitis. Epilepsy Behav 49:280–285
11. Kim H, Ryu H, Kang JK (2015) Anti-NMDA receptor antibody encephalitis presenting with unilateral non-convulsive status epilepticus in a male patient. J Epilepsy Res 5:17–19
12. Foff EP, Taplinger D, Suski J et al (2016) EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis. Clin EEG Neurosci. doi:10.1177/1550059416642660
13. Tobin WO, Strand EA, Clark HM et al (2014) NMDA receptor encephalitis causing reversible caudate changes on MRI and PET imaging. Neurol Clin Pract 4:470–473
14. Ellis ME, Diehl LF, Granger E et al (1989) Trephine needle bone marrow biopsy in the initial staging of Hodgkin disease: sensitivity and specificity of the Ann Arbor staging procedure criteria. Am J Hematol 30:115–120
15. Wright S, Hacohen Y, Jacobson L et al (2015) N-methyl-d-aspartate receptor antibody-mediated neurological disease: results of a UK-based surveillance study in children. Arch Dis Child 100:521–526
16. Locasciulli A, Bacigalupo A, Van Lint MT et al (1990) Hepatitis B virus (HBV) infection and liver disease after allogeneic bone marrow transplantation: a report of 30 cases. Bone Marrow Transpl 6:25–29
17. Kuroda Y (2016) Neurocritical care update. J Intensive Care 4:36
18. Leitinger M, Kalss G, Rohracher A et al (2015) Predicting outcome of status epilepticus. Epilepsy Behav 49:126–130
19. Chanson E, Bicilli E, Lauxerois M et al (2016) Anti-NMDA-R encephalitis: should we consider extreme delta brush as electrical status epilepticus? Neurophysiol Clin 46:17–25
20. Matoq AA, Rappoport AS, Yang Y et al (2015) Anti-NMDA-receptor antibody encephalitis in infants. Epilepsy Behav Case Rep 4:99–101
21. Alsaadi T, Shakra M, Turkawi L et al (2015) VNS terminating refractory nonconvulsive SE secondary to anti-NMDA encephalitis: a case report. Epilepsy Behav Case Rep 3:39–42
22. Kadoya M, Onoue H, Kadoya A et al (2015) Refractory status epilepticus caused by anti-NMDA receptor encephalitis that markedly improved following combination therapy with rituximab and cyclophosphamide. Intern Med 54:209–213
23. Barros P, Brito H, Ferreira PC et al (2014) Resective surgery in the treatment of super-refractory partial status epilepticus secondary to NMDAR antibody encephalitis. Eur J Paediatr Neurol 18:449–452
24. Marques IB, Teotonio R, Cunha C et al (2014) Anti-NMDA receptor encephalitis presenting with total insomnia–a case report. J Neurol Sci 336:276–280
25. Finne Lenoir X, Sindic C, van Pesch V et al (2013) Anti-N-methyl-d-aspartate receptor encephalitis with favorable outcome despite prolonged status epilepticus. Neurocrit Care 18:89–92
26. Pinho J, Rocha J, Rodrigues M et al (2012) Diversity in anti-N-methyl-d-aspartate receptor encephalitis: case-based evidence. Psychiatry Clin Neurosci 66:153–156
27. Goldberg EM, Taub KS, Kessler SK et al (2011) Anti-NMDA receptor encephalitis presenting with focal non-convulsive status epilepticus in a child. Neuropediatrics 42:188–190
28. Kirkpatrick MP, Clarke CD, Sonmezturk HH et al (2011) Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis. Epilepsy Behav 20:392–394
29. Adamec C (1966) The use of Spearman’s correlation order coefficient in validation. Cesk Zdrav 14:100–102